Massive intravenous immunoglobulin treatment in pregnancy complicated by Guillain–Barré Syndrome

2001 ◽  
Vol 97 (1) ◽  
pp. 101-104 ◽  
Author(s):  
Hideto Yamada ◽  
Noriko Noro ◽  
Emi H Kato ◽  
Yasuhiko Ebina ◽  
Kazutoshi Cho ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Immunoglobulin Treatment ◽  
Guillain Barré ◽  
In Pregnancy

Intravenous Immunoglobulin Treatment in Children with Guillain-Barre Syndrome

1995 ◽  
Vol 27 (3) ◽  
pp. 241-243 ◽  
Author(s):  
Nuran Gürses ◽  
Serap Uysal ◽  
Feyzullah Çetinkaya ◽  
Ismail Işek ◽  
Ayhan Gazi Kalayci
Keyword(s):  
Intravenous Immunoglobulin ◽  
Guillain Barre Syndrome ◽  
Guillain Barré Syndrome ◽  
Immunoglobulin Treatment ◽  
Guillain Barré

scholarly journals Rescue treatment in patients with poorly responsive Guillain–Barre syndrome

2019 ◽  
Vol 7 ◽  
pp. 205031211984019 ◽  
Author(s):  
Ayman Mahmoud Alboudi ◽  
Pournamy Sarathchandran ◽  
Samar Sameer Geblawi ◽  
Deeb Maxwell Kayed ◽  
Jihad Inshasi ◽  
...  
Keyword(s):  
Plasma Exchange ◽  
Intravenous Immunoglobulin ◽  
Guillain Barre Syndrome ◽  
Line Treatment ◽  
Second Line ◽  
Rescue Treatment ◽  
Significant Difference ◽  
Guillain Barré Syndrome ◽  
Immunoglobulin Treatment ◽  
Guillain Barré

Objectives: To evaluate the effectiveness of rescue treatment (intravenous immunoglobulin or plasma exchange) in patients with Guillain–Barre syndrome who did not respond or deteriorated after the initial management with intravenous immunoglobulin. Methods: We performed a retrospective review of the medical records of patients who responded poorly or did not respond to intravenous immunoglobulin treatment. The disability parameters of those who received second-line treatment with intravenous immunoglobulin or plasma exchange (20 patients) were compared with those who did not receive second-line treatment (19 patients). Results: There was a statistically significant improvement in disability scores at 1 month in the patients who received the rescue treatment (p = 0.033). However, there was no significant difference in the disability scores at 3 and 6 months, or in length of intensive care unit stay. Conclusion: Our study showed that a second course of treatment to carefully selected patients may be beneficial

Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome

2017 ◽  
Vol 40 (5) ◽  
pp. 224-225 ◽  
Author(s):  
Elif Uygur Kucukseymen ◽  
Burcu Yuksel ◽  
Fatma Genc ◽  
Eylem Ozaydin Goksu ◽  
Sevim Yildiz ◽  
...  
Keyword(s):  
Intravenous Immunoglobulin ◽  
Guillain Barre Syndrome ◽  
Splenial Lesion ◽  
Guillain Barré Syndrome ◽  
Immunoglobulin Treatment ◽  
Guillain Barré ◽  
Reversible Splenial Lesion Syndrome

Association of Neutrophil/Lymphocyte Ratio With Intravenous Immunoglobulin Treatment in Children With Guillain-Barré Syndrome

2018 ◽  
Vol 33 (2) ◽  
pp. 164-167 ◽  
Author(s):  
Ezgi Altuntas Hüner ◽  
Alper I. Dai ◽  
Abdullah T. Demiryürek
Keyword(s):  
Nervous System ◽  
Intravenous Immunoglobulin ◽  
Medical Records ◽  
University Hospital ◽  
Guillain Barre Syndrome ◽  
Neutrophil Lymphocyte Ratio ◽  
Immune Mediated ◽  
Guillain Barré Syndrome ◽  
Immunoglobulin Treatment ◽  
Guillain Barré

Guillain-Barré syndrome (GBS) is an acute immune-mediated inflammatory polyneuropathy of the peripheral nervous system. The authors aimed to investigate whether the neutrophil/lymphocyte (N/L) and platelet/lymphocyte (P/L) ratios are the parameters that associated with the drug treatment or severity of GBS. Twenty-seven children with GBS were retrospectively analyzed from the medical records of patients who attended to the Pediatric Neurology Department of the Gaziantep University Hospital. Biochemical and hematologic parameters were measured. Leukocytes, neutrophils counts and N/L ratio were significantly higher before the intravenous immunoglobulin treatment ( P < .001). However, there were no marked differences in platelet count and P/L ratio. In addition, marked correlation was observed between the N/L ratio after treatment and duration of weakness. The results of the study showed that N/L ratio is significantly higher in GBS patients, and reduces following with intravenous immunoglobulin treatment.

Sign in / Sign up

Export Citation Format

Share Document